Spots Global Cancer Trial Database for Stellate Ganglion Block to Reduce Hot Flushes

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Stellate Ganglion Block to Reduce Hot Flushes

Official Title: Short-term Efficacy of Stellate Ganglion Block to Reduce Hot Flushes

Study ID: NCT03756272

Conditions

Hot Flash

Stellate Ganglion Block

Postmenopausal

Hot Flushes

Interventions

Bupivacaine block

Placebo ganglion block

Study Description

Brief Summary: To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure

Detailed Description: Hot flushes are the most common symptom of menopause for which postmenopausal (PMP) women seek medical help, in 20% of PMP women hot flushes can persist for up to 15 years. A possible treatment for hot flushes is stellate ganglion block (SGB), used as a means to interrupt parts of the sympathetic nervous system involved in temperature regulation. Single centre randomized double blind placebo controlled intervention study Study period of 6 months in which patients will fill out on set time points 5 questionnaires regarding quality of life and keep a diary on hot flush frequency and severity during1 week on the same time points. Study population: Postmenopausal women aged 30-70 years old with no other causes of flushing present. Intervention (if applicable) Intervention: Stellate ganglion block versus sham procedure Follow up with questionnaires during 6 months.